KIRITSY CHRISTOPHER P exercised Palvella Therapeutics Options at $127.20 per share and sold the related shares at $157 on Sep. 2, 2026. The director’s reported derivative holdings fell to zero afterward, while the transaction also changed his direct share ownership.

Key Highlights

  • The option exercise was recorded under SEC transaction code M.
  • The subsequent Palvella share sale carried SEC transaction code S.
  • KIRITSY CHRISTOPHER P’s reported derivative holdings reached zero after the transactions.

KIRITSY CHRISTOPHER P exercised options in Palvella Therapeutics at $127.20 per share on Sep. 2, 2026, then sold the related shares at $157 per share the same day. The director’s reported derivative holdings were zero after the transactions.

Option Exercise and Same-Day Sale

The option exercise was recorded under SEC transaction code M. A separate transaction recorded the sale of Palvella shares at $157 per share under code S. The source identifies KIRITSY CHRISTOPHER P as a director of Palvella Therapeutics. The transactions took place on Sep. 2, 2026.

Reported Ownership After Transactions

Following the option exercise, KIRITSY CHRISTOPHER P’s reported direct share ownership was higher than after the subsequent sale. The share sale reduced that direct ownership. The reported derivative securities balance was zero after the option exercise transaction. The sequence therefore left separate direct and derivative holdings at different reported levels.